In Vitro and In Vivo Activity of Amoxicillin–Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae

Infections due to extended-spectrum β-lactamase (ESBL)–producing Enterobacterales are an increasingly common problem. For many of these infections, no oral treatment options are available. The activity of amoxicillin–clavulanate combined with ceftibuten or cefpodoxime was evaluated against a group o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2022-04, Vol.28 (4), p.419-424
Hauptverfasser:	Gupta, Aanchal, Malik, Saquib, Kaminski, Monica, Landman, David, Quale, John M
Format:	Artikel
Sprache:	eng
Schlagworte:	Amoxicillin Amoxicillin-Potassium Clavulanate Combination - pharmacology Amoxicillin-Potassium Clavulanate Combination - therapeutic use Anti-Bacterial Agents - pharmacology Antibiotics beta-Lactamases - genetics Cefpodoxime Ceftibuten Ceftizoxime - analogs & derivatives Cephalosporins Clinical isolates E coli Escherichia coli Infections Klebsiella Klebsiella pneumoniae Larvae Mechanisms Microbial Sensitivity Tests Minimum inhibitory concentration Penicillin Sepsis Survival β Lactamase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!